KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other Non-Current Assets (2016 - 2026)

Pacific Biosciences Of California has reported Other Non-Current Assets over the past 16 years, most recently at $8.8 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 294.82% year-over-year to $8.8 million; the TTM value through Dec 2025 reached $8.8 million, up 294.82%, while the annual FY2025 figure was $8.8 million, 294.82% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $8.8 million at Pacific Biosciences Of California, up from $1.5 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $8.8 million in Q4 2025 and troughed at $1.5 million in Q2 2025.
  • A 5-year average of $3.3 million and a median of $2.7 million in 2023 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 41.23% in 2023 and later skyrocketed 294.82% in 2025.
  • Year by year, Other Non-Current Assets stood at $5.1 million in 2021, then plummeted by 36.72% to $3.2 million in 2022, then decreased by 15.52% to $2.7 million in 2023, then dropped by 18.37% to $2.2 million in 2024, then skyrocketed by 294.82% to $8.8 million in 2025.
  • Business Quant data shows Other Non-Current Assets for PACB at $8.8 million in Q4 2025, $1.5 million in Q3 2025, and $1.5 million in Q2 2025.